ebook img

Diabetic Medicine: A Journal of the British Diabetic Association 1999: Vol 16 Index PDF

15 Pages·1999·2.5 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Diabetic Medicine: A Journal of the British Diabetic Association 1999: Vol 16 Index

Indexes Author Index Arif, S. see Ejskjaer, N.T. Arner, P. see Landstedt-Hallin, L. Aage Mortensen, S. see Henriksen, J.E. Arnqvist, H.J. see Lindstrom, T. Abbott, C.A. see Van Schie, C.H.M. Asatiani, N. see Hod, M. Abraha, A., Schultz, C., Konopelska-Bahu, T., James, T., Watts, Atkinson, A.B. see Hunter, S.J. A., Stratton, I.M., Matthews, D.R. 8c Danger, D.B. Glycaemic Atkinson, A.B. see Mcallister, A.S. control and familial factors determine hyperlipidaemia in early Atlan-Gepner, C. see Zevaco-Mattei, C. childhood diabetes, 598 Avogaro, A. see Trojan, N. Adachi, Y. see Ito, K. Ayis, S.A.M. see Patel, S. Addison, G.M. see Kilpatrick, E.S. Adler, G. see Flechtner-Mors, M. Adojaan, B. see Padaiga, Z. Babaya, N. see Fujisawa, T. Ahmed, M. see Gottsater, A. Backlund, L.B. see Garpenstrand, H. Ahmed, S., Bennett, S.T., Huxtable, S.J., Todd, J.A,, Matthews, Baigent, C. 8c Peto, R. Safety of metformin in Type 2 diabetes D.R. 8c Gough, S.C.L. INS VNTR allelic variation and mellitus, 89 dynamic insulin secretion in healthy adult non-diabetic Balkau, B. & Charles, M.A. Comment on the provisional report Caucasian subjects, 910 from the WHO consultation, 442 Ahn, Y.-B. see Song, K.-H Banga, J.-D. see Kanters, S.D.J.M. Akram, J., De Verga, V. 8c The Ramadan Study Group. Insulin Bar, J. see Hod, M. lispro (Lys(B28), Pro(B29)) in the treatment of diabetes Barakat, M.T. see Colhoun, H.M. mellitus during the fasting month of Ramadan, 861 Bardini, G. see Mannucci, E. Alberti, H. Diabetes in Africa, 971 Bartlett, W.A. see Bayly, G.R. Alberti, K.G.M.M. see Patel, S. Baumer, J.H. see Zhao, H.X. Alberti, K.G.M.M. Severe diabetic Ketoacidosis: a comment, 350 Bayly, G.R., Bartlett, W.A., Davies, P.H., Husband, D., Alberti, K.G.M.M., Daly, M.E., Robinson, A., Marshall, S.M. 8c Haddon, A., Game, F.L. &i Jones, A.F. Laboratory-based Mathers, J.C. The short insulin tolerance test is safe and calculation of coronary heart disease risk in a hospital reproducible, 352 diabetic clinic, 697 Alessandrini, P. see Moro, E. Beck-Nielsen, H. see Christiansen, C. Algra, A. see Kanters, S.D.J.M. Beck-Nielsen, H. see Henriksen, J.E. Alt, A. see Flechtner-Mors, M. Belch, J. see Elhadd, T. Ambrosi, F. see Gregorio, F. Bell, G.l. see Ng, M.C.Y. Amiel, S.A. A new beginning.’, 1 Bell, P..M. see Hunter, S.J. Amiel, S.A. An ace in the hole?, 887 Bell, P.M. see Willis, A.M. Amiel, S.A. Blood glucose control in pregnancy, 621 Benbow, S.J., Cossins, L. 8c Macfarlane, LA. Painful diabetic Amiel, S.A. Diabetes and driving - an insular approach, 271 neuropathy, 632 Amiel, S.A. Hale and farewell, 977 Bennett, F. see Wilks, R. Amiel, S.A. New ventures for Diabetic Medicine, 709 Bennett, S.T. see Ahmed, S. Amiel, S.A. Small is beautiful - but too cheap, 445 Benthake, H. see Rausch, U. Ammari, F. see Davies, M.J. Bergamini, L. see Riccardi, G. Ammari, F., Davies, M.J., Koppiker, N., Gregory, R. 8c Burden, Berger, W. see Stahl, M. A.C. Effect of gliclazide on plasma insulin, intact and 32/33 Betts, P.R, Logatchov, M., Volkov, L, Murphy, H., split proinsulin in South Asian subjects with Type 2 diabetes Dombrowskaya, N., Borzikh, S., Ivanova, L, Twyman, S., mellitus, 142 Vartan On Behalf Of The Paediatric Teams In Moscow, Tula, Anand, P. see Diemel, L.T. Tambov 8c Southampton, J. An assessment of paediatric Anderson, J.H. see Garg, S.K. diabetes care in three centres in Russia and in Southampton, Anderson, R.A. see Ravina, A. UK, 772 Anderson, S.G. see Wilks, R. Bhopal, R. see Patel, S. Annala, A.-P. see Koivukangas, V. Bianchi, C. see Riccardi, G. Anthony, P. see Brash, P.D. Bilo, H.J.G. see Goddijn, P.P.M. Antonellis, A. see Malecki, M.T. Bingley, P.J. see Laing, S.P. Apostolou, O. see Sotiropoulos, A. Bingley, P.J. see Laing, S.P. Appleton, M. see Lee, B.C. Bittolo Bon, G. see Moro, E. ©1999 British Diabetic Association. Diabetic Medicine, 16, 1051-1064 1051 1052 Indexes Bjorntorp, P., Holm, G. &C Rosmond, R. Hypothalamic arousal, Carson, D.J. see Hargrave, D.R. insulin resistance and Type 2 diabetes mellitus, 373 Casamitjana, R. see Rodriguez-Villar, C. Blann, A.D. see Elhadd, T. Cazzolato, G. see Moro, E. Boavida, ). see Collado-Mesa, F. Cecil, A. see Simmons, D. Bobbioni, E. see Buysschaert, M. Celermajer, D.S. see McFarlane, R. Bodansky, H.J. see Fear, N.T. Cepaitis, Z. see Padaiga, Z. Bodansky, H.J. see Freeman, M.S. Cha, B.-Y. see Song, K.-H Bolinder, J. see Landstedt-Hallin, L. Chan, A.K.F. see Duffin, A.C. Bolton, C.H. see Pinkney, J.H. Chan, J.C.N. see Ko, G.T.C. Bonney, M.-A. see Mcfarlane, R. Chan, J.C.N. see Ng, M.C.Y. Booth, A. see Mason, J. Chan, N.N., Brain, H.P.S. 8c Feher, M.D. Metformin-associated Borch-Johnsen, K. Evidence-based prevention of cardiovascular lactic acidosis: a rare or very rare clinical entity?, 273 disease, 177 Chan, W.-B. see Ko, G.T.C. Borch-Johnsen, K. see Olsen, B.S. Chang, C.-T. see Chen, C.C. Borzikh, S. see Betts, P.R Chanturia, T. see Hod, M. Bosman, D.R. Molecular and Cell Biology of Type 2 Diabetes and Charbonnel, B. see Colombel, A. Its Complications, 527 Charles, M.A. see Balkan, B. Botha, J.L. see Goyder, E.C. Chase, H.P. see Garg, S.K. Botha, J.L. see Laing, S.P. Chaturvedi, N. see Yudkin, J.S. Botti, G. see Zevaco-Mattei, C. Chaudhuri, K.R. see Winkler, A.S. Boulton, A.J.M. see Jude, E.B. Chen, C.C. 8c Chang, C.-T. Is the short insulin tolerance test safe Boulton, A.J.M. see Tentolouris, N. and reproducible?, 353 Boulton, A.J.M. see Van Schie, C.H.M. Chen, H.S. see Hwu, C.M. Boyce, D. see Clarke, C.F. Chow, C.-C see Ng, M.C.Y. Bradley, C. see Pierce, M. Christensen, N.J. see Nielsen, F.S. Bradley, J.L. see Ejskjaer, N.T. Christensen, P.K., Rossing, P., Nielsen, F.S. 8c Parving, H.-H. Brain, H.P.S. see Chan, N.N. Natural course of kidney function in Type 2 diabetic patients Brash, P.D., Foster, J., Vennart, W., Anthony, P. 8c Tooke, J.E. with diabetic nephropathy, 388 Magnetic resonance imaging techniques demonstrate soft Christiansen, C., Poulsen, P. 8c Beck-Nielsen, H. The Trp64Arg tissue damage in the diabetic foot, 55 mutation of the adrenergic (1-3 receptor gene impairs insulin Brigis, G. see Padaiga, Z. secretion: a twin study, 835 Bruce, C. see Fraser, R.B. Clarke, C.F., Eason, M., Reilly, A., Boyce, D. 8c Werther, G.A. Brunetti, P. see Riccardi, G. Autonomic nerve function in adolescents with Type 1 diabetes Bruun Andersen, C. see Henriksen, J.E. mellitus: relationship to microalbuminuria, 550 Bryant, V.M., Wilson, A., Jones, T.H. & Hague, R.V. A high- Clarkson, P. see Meeking, D.R. uptake eye and foot screening service for an urban population, Clements, G.B. see Nairn, C. 609 Cockburn, B.N. see Ng, M.C.Y. Bryden, N.A. see Ravina, A. Cockcroft, J.R. see Gazis, A. Burden, A.C. see Ammari, F. Cockram, C.S. see Ko, G.T.C. Burden, A.C. see Davies, .M.J. Cockram, C.S. see Ng, M.C.Y. Burden, A.C. see Laing, S.P. Colhoun, H.M. see Collado-Mesa, F. Burden, M.L. see Davies, M.J. Colhoun, H.M., Dong, W., Barakat, M.T., Mather, H.M. 8c Buxton-Thomas, M.S. see Ejskjaer, N.T. Poulter, N.R. The scope for cardiovascular disease risk factor Buysschaert, M., Bobbioni, E., Starkie, M., Frith, L. & The intervention among people with diabetes mellitus in England: Troglitazone Study Group. Troglitazone in combination with a population-based analysis from the Health Surveys for sulphonylurea improves glycaemic control in Type 2 diabetic England 1991-94,35 patients inadequately controlled by sulphonylurea therapy Collado-Mesa, F., Colhoun, H.M., Stevens, L.K., Boavida, J., alone, 147 Ferriss, J.B., Karamanos, B., Kempler, P., Michel, G., Roglic, Byrne, C.D., Maison, P., Halsall, D., Martensz, N., Hales, C.N. & G., Fuller, J.H. 8c The EURODIAB IDDM Complications Wareham, N.J. Cross-sectional but not longitudinal associa¬ Study Group, J.H. Prevalence and management of hyperten¬ tions between non-esterified fatty acid levels and glucose sion in Type 1 diabetes mellitus in Europe: the EURODIAB intolerance and other features of the metabolic syndrome, 1007 IDD.M Complications Study, 41 Colman, P.G. see Wood, D.M. Cai, F. see Diemel, L.T. Colombel, A., Murat, A., Krempf, M., Kuchly-Anton, B. 8c Carle, F. see Gregorio, F. Charbonnel, B. Improvement of blood glucose control in Type Carron Brown, S., Kyne-Grzebalski, D., Mwangi, B. 8c Taylor, R. 1 diabetic patients treated with lispro and multiple NPH Effect of management policy on 120 Type 1 diabetic injections, 319 pregnancies: policy decisions in practice, 573 Conget, 1. see Costa, A. Carsky, J. see Muchova, J. Conget, 1. see Rodriguez-Villar, C. , ©1999 British Diabetic Association. Diabetic Medicine, 16 1051-1064 i»:7i Indexes 1053 Connell, J.M.C. see Kennon, B. Duffin, A.C., Donaghue, K.C., Potter, M., .Mcinnes, A., Chan, Connor, H. Diabetic foot disease - where is the evidence?, 799 A.K.F., King, J., Howard, N.J. 8c Silink, M. Limited joint Connor, H. see Jude, E.B. motility in the hands and feet of adolescents with Type 1 Contadini, S. see Riccardi, G. diabetes mellitus, 125 Cooper, R.S. see Wilks, R. Dunger, D.B. see Abraha, A. Coppini, D.V., Weng, C. & Sonksen, P.H. Achilles’ tendon Durackova, Z. see Muchova, J. squeeze test: a quick, easy and cheap way to identify the at-risk Durrington, P.N. see Julier, K. foot?, 793 Dworak, O. see Winkler, G. Cossins, L. see Benbow, S.J. Costa, A. 8c Conget, I. Fasting plasma glucose dianostic criteria Eason, M. see Clarke, C.F. for diabetes mellitus. Reply, 970 Eaton, S. see Rajbhandari, S. Costa, A., Rios, M., Fernandez, M., Gomis, R. 8c Conget, 1. The Edmonds, M.E. see Ejskjaer, N.T. 1997 ADA diabetes diagnostic categories: impact on Edmonds, M.E. see Mantey, 1. employees’ annual medical examination, 528 Egberts, E.-H. see Holstein, A. Coulter, W.A. see Willis, A.M. Ejskjaer, N.T., Arif, S., Dodds, W., Zanone, M..M., Vergani, D., Critchley, J.A.J.H. see Ng, M.C.Y. Watkins, P.J. 8c Peakman, M. Prevalence of autoantibodies to Cronin, C.C. see O’connor, T.M. autonomic nervous tissue structures in Type 1 diabetes Crook, J.R. see Meeking, D.R. mellitus, 544 Cruickshank, J.K. see Wilks, R. Ejskjaer, N.T., Bradley, J.L., Buxton-Thomas, M.S., Edmonds, Cseh, K. see Winkler, G. M.E., Howard, E.R., Purewal, T., Thomas, P.K. 8c Watkins, Cummings, M.H. see Meeking, D.R. P.J. Novel surgical treatment and gastric pathology in diabetic Curtis, S. see Malecki, M.T. gastroparesis, 488 Ekblom, J. see Garpenstrand, H. Dahlquist, G. see Padaiga, Z. Elhadd, T., Kirk, G., Mclaren, M., Newton, R., Greene, S., Belch, Daly, M.E. see Alberti, K.G.M.M. J., Lip, G.Y.H. 8c Blann, A.D. Endothelial integrity, soluble David-Dufilho, M. see Miossec, P. adhesion molecules and platelet markers in Type 1 diabetes Davies, M., Muehlbayer, .S., Garrick, P. 8c Mcnally, P.G. Potential mellitus, 86 impact of a change in the diagnostic criteria for diabetes Elphick, A. see Hod, M. mellitus on the prevalence of abnormal glucose tolerance in a Endo, G. see Uchimoto, S. local community at risk of diabetes: impact of new diagnostic Ennis, C.N. see Hunter, S.J. criteria for diabetes mellitus, 343 Ercilla, G. see Rodriguez-Villar, C. Davies, M.J. 8c Burden, A.C. Screening for type 2 diabetes mellitus Erkelens, D.W. see Kanters, S.D.J.M. in the UK Indo-Asian population. Reply, 795 European Diabetes Policy Group 1998. Adesktop guide toType 1 Davies, M.J. see Ammari, F. (insulin-dependent) diabetes mellitus, 253 Davies, M.J., Ammari, F., Sherriff, C., Burden, M.L., Gujral, J. 8c European Diabetes Policy Group 1999. A desktop guide to Type 2 Burden, A.C. Screening for Type 2 diabetes mellitus in the UK diabetes mellitus, 716 Indo-Asian population, 131 Davies, P.H. see Bayly, G.R. Farmer, A., Levy, J.C. 8c Turner, R.C. Knowledge of risk of Dawson, K.G. see Gerstein, H.C. developing diabetes mellitus among siblings of Type 2 diabetic Day, C. Thiazolidiones: a new class of antidiabetic drugs, 179 patients, 233 De Bruin, T.W.A. see Kanters, S.D.J.M. Fear, N.T., Mckinney, P.A., Patterson, C.C., Parslow, R.C. De Verga, V. see Akram, J. 8c Bodansky, H.J. Childhood Type 1 diabetes mellitus Dean, J.D. see Julier, K. and parental occupations involving social mixing and Demaine, A.G. see Zhao, H.X. infectious contacts: two population-based case-control Deng, X.X see Li, C.L. studies, 1025 Devynck, M.A. see Miossec, P. Feher, M.D. see Chan, N.N. Diemel, L.T., Cai, F., Anand, P., Warner, G., Kopelman, P.G., Feher, M.D. see Lawrenson, R. Fernyhough, P. 8c Tomlinson, D.R. Increased nerve growth Fernandez, M. see Costa, A. factor mRNA in lateral calf skin biopsies from diabetic Fernlund, P. see Gottsater, A. patients, 113 Fernyhough, P. see Diemel, L.T. Ditschuneit, H.H. see Flechtner-Mors, M. Ferriss, J.B. see Collado-Mesa, F. Dodds, W. see Ejskjaer, N.T. Feskens, E.J.M. see Goddijn, P.P.M. Dombrowskaya, N. see Betts, P.R Festa, A., Shnawa, N., Krugluger, W., Hopmeier, P., Donaghue, K.C. see Duffin, A.C. Schernthaner, G. 8c Haffner, S.M. Relative hypoleptinaemia Donald, A. see Meeking, D.R. in women with mild gestational diabetes mellitus, 656 Dong, W. see Colhoun, H.M. Filipponi, P. see Gregorio, F. Dowey, J.A. Dental care of patients with diabetes mellitus, 173 Finn, J.-R. see Ruhnau, K.-J Downs, L see Pinkney, J.H. Fiore, G. see Galeone, F. Drucquer, M. see Goyder, E.C. Firth, R.G. see O’Connor, T.M. © 1999 British Diabetic Association. Diabetic Medicine, 16, 1051-1064 •:jii 1054 Indexes Fisher, B.M. Interventional cardiology in people with diabetes, (SSAO) activity in Type 2 diabetes mellitus complicated by 531 retinopathy, 514 Fisher, J. see Taylor, D.J. Garrick, P. see Davies, M. Fisher, L. see Lernmark, B. Gazis, A., White, D.J., Page, S.R. 8c Cockcroft, J.R. Effect of oral Fisken, R.A. Severe diabetic ketoacidosis: the need for large doses vitamin E (a-tocopherol) supplementation on vascular en¬ of insulin, 347 dothelial function in Type 2 diabetes mellitus, 304 Flechtner-Mors, M., Ditschuneit, H.H., Jenkinson, C.P., Alt, A. Genetics Group, J. see Lorenzen, T. & Adler, G. Metformin inhibits catecholamine-stimulated Gerstein, H.C., Reddy, S.S.K., Dawson, K.G., Yale, J.F., Shannon, lipolysis in obese, hyperinsulaemic, hypertensive subjects in S. 8c Norman, G. A controlled evaluation of a national subcutaneous adipose tissue: an in situ microdialysis study, continuing medical education programme designed to im¬ 1000 prove family physicians’ implementation of diabetes-specific Forrester, T. see Wilks, R. clinical practice guidelines, 964 Foster, A.V.M. see Mantey, 1. Gill, G.V. see Weston, P.J. Foster, J. see Brash, P.D. Goddijn, P.P.M., Bilo, H.J.G., Feskens, E.J.M., Groenier, Fourie, J.M. see Levitt, N.S. K.H., Van Der Zee, K.I. 8c Meyboom-De Jong, B. Fraser, R.B. 8c Bruce, C. Amniotic fluid insulin levels identify the Longitudinal study on glycaemic control and quality of fetus at risk of neonatal hypoglycaemia, 568 life in patients with Type 2 diabetes mellitus referred for Freeman, M.S. 8c Bodansky, H.J. Effectiveness of treatment for intensified control, 23 impotence in diabetic men, 1048 Goh, K.L. see Tooke, J.E. Frith, L. see Buysschaert, M. Golay, A. see Morel, Y. Fujii, -M. see Ito, K. Gomis, R. see Costa, A. Fujii, S. see Uchimoto, S. Gomis, R. see Rodriguez-Villar, C. Fujisawa, T., Ikegami, H., Kawaguchi, Y., Yamato, E., Gonzalez, E. see Garay-Sevilla, M.E. Nakagawa, Y, Shen, G.-Q., Fukuda, M. 8c Ogihara, T. Length Goto, H. see Ito, K. rather than a specific allelle of dinucleotide repeat in the 5 Gottsater, A., Ahmed, M.,Fernlund,P.8cSundkvist,G. Autonomic -upstream region of the aldose reductase gene is associated with neuropathy in Type 2 diabetic patients is associated with diabetic retinopathy, 1044 hyperinsulinaemia and hypertriglyceridaemia, 49 Fujisawa, T., Ikegami, H., Yamamoto, E., Kawaguchi, Y., Ueda, Gough, S.C.L. see Ahmed, S. H., Shintani, M., Nojima, K., Kawabata, Y., Ono, M., Goyder, E.C., Spiers, N., Mcnally, P.G., Drucquer, M. 8c Botha, Nishino, T., Noso, S., Yamada, K., Babaya, N., Okamoto, N., J.L. Do diabetes clinic attendees stay out of hospital? A Ohguro, N., Eukuda, M. 8c Oghiara, T. Association of plasma matched case-control study, 687 fibrinogen level and blood pressure with diabetic nephropathy, Gravholt, H. see 0rskov, L. and renal complications associated with proliferative diabetic Greene, S. see Elhadd, T. retinopathy, in Type 2 diabetes mellitus, 522 Gregorio, F., Ambrosi, F., Manfrini, S., Velussi, M., Carle, F., Fukuda, M. see Fujisawa, T. Testa, R., Merante, D. 8c Filipponi, P. Poorly controlled Fuller, J.H. see Collado-Mesa, F. elderly Type 2 diabetic patients: the effects of increasing Fulton, C.R. see Willis, A.M. sulphonylurea dosages or adding metformin, 1016 Gregory, R. see Ammari, F. Gabazza, E.C. see Ito, K. Groeneveld, Y., Petri, H., Hermans, J. 8c Springer, M.P. Gaddi, O., Tortorella, G., Picano, E., Pantaleoni, M., Manicardi, Relationship between blood glucose level and mortality in E., Varga, A., Moneta, 1. 8c Guiducci, U. Diagnostic and Type 2 diabetes mellitus: a systematic review, 2 prognostic value of vasodilator stress echocardiography in Groenier, K.H. see Goddijn, P.P.M. asymptomatic Type 2 diabetic patients with positive exercise Groop, L. see Landstedt-Hallin, L. thallium scintigraphy: a pilot study, 762 Guiducci, U. see Gaddi, O. Gadour, M. see Rajbhandari, S. Gujral, J. see Davies, M.J. Galbraith, D.N. see Nairn, C. Gulliford, M.C. 8c Mahabir, D. A five-year evaluation of Galeone, E., Eiore, G. 8c Mannucci, E. Medium-term hypo- intervention in diabetes care in Trinidad and Tobago, 939 glycaemic effects of two different oral formulations of Gulliford, M.C. 8c Mejia, A. Trends in diabetes mellitus in gliclazide, 618 Greater London, 1991-2011. associations with ethnicity, 174 Game, F.L. see Bayly, G.R. Gutierrez-Roa, A. see Garay-Sevilla, M.E. Garaiova, 1. see Muchova, J. Garay-Sevilla, M.E., Malacara, J.M., Gutierrez-Roa, A. 8c Haddon, A. see Bayly, G.R. Gonzalez, E. Denial of disease in Type 2 diabetes mellitus: its Haffner, S.M. see Festa, A. influence on metabolic control and associated factors, 238 Hague, R.V. see Bryant, V.M. Garg, S.K., Anderson, J.H., Perry, S.V., Mackenzie, T., Keith, P., Hales, C.N. see Byrne, C.D. Jennings, M.K., Hansen, M.M. 8c Chase, H.P. Long-term Halsall, D. see Byrne, C.D. efficacy of Humalog® in subjects with Type 1 diabetes Hambley, H. see Winkler, A.S. mellitus, 384 Hanefeld, M., Temelkova-Kurktschiev, T., Schaper, F., Henkel, Garpenstrand, H., Ekblom, J., Biicklund, L.B., Oreland, L. 8c E., Siegert, G. 8c Koebler, C. Impaired fasting glucose is not a Rosenqvist, U. Elevated plasma semicarbazide-sensitive risk factor for atherosclerosis, 212 , ©1999 British Diabetic Association. Diabetic Medicine, 16 1051-1064 Indexes 1055 Hansen, H.P. see Nielsen, F.S. thiazide diuretic on insulin action in hypertensive type 2 Hansen, M.M. see Garg, S.K. diabetic patients: a double blind crossover study, 482 Hargrave, D.R., Mcmaster, C., O’hare, M.M.T. &: Carson, D.J. Husband, D. see Bayly, G.R. Tobacco smoke exposure in children and adolescents with Hutchinson, A. see Mason, J. diabetes mellitus, 31 Huxtable, S.J. see Ahmed, S. Harland, J. see Patel, S. Hwu, C.M., Kwok, C.F., Chen, H.S., Shih, K.C., Lee, S.H., Hsiao, Harmos, G. see Winkler, G. L.C., Lin, S.H. & Ho, L.T. Lack of effect of simvastatin on Harper, V. see Mires, G.J. insulin sensitivity in Type 2 diabetic patients with hypercho- Harris, N.D. & Heller, S.R. Sudden death in young patients with lesterolaemia: results from a double-blind, randomized, Type 1 diabetes: a consequence of disease, treatment or both?, placebo-controlled crossover study, 749 623 Harris, N.D. see Rajhhandari, S. Ichikawa, F., Yamada, K., Ishiyama-Shigemoto, S., Yuan, X. & Hattersley, A.T. see Lee, B.C. Nonaka, K. Association of an (A-C)n dinucleotide repeat Hawthorne, K. &c Tomlinson, S. Pakistani moslems with Type 2 polymorphic marker at the 5'-region of the aldose reductase diabetes mellitus: effect of sex, literacy skills, known diabetic gene with retinopathy hut not with nephropathy or neuro¬ complications and place of care on diabetic knowledge, pathy in Japanese patients with Type 2 diabetes mellitus, 744 reported self-monitoring management and glycaemic control, Ikegami, H. see Fujisawa, T. 591 Ilonen, J. see Nejentsev, S. Hayashi, T. see Uchimoto, S. lori, E. see Trojan, N. Hayes, J.R. see Willis, A.M. Ishiyama-Shigemoto, S. see Ichikawa, F. Hayworth, J. see Pierce, M. Ito, K., Nakatani, K., Fujii, M., Katsuki, A., Tsuchihashi, K., Heinemann, L., Sinha, K., Weyer, C., Loftager, M., Hirschberger, Murata, K., Goto, H., Yano, Y., Gahazza, E.C., Sumida, Y. & S. & Heise, T. Time-action profile of the soluble, fatty acid Adachi, Y. Codon 54 polymorphism of the fatty acid binding acylated, long-acting insulin analogue NN304, 332 protein gene and insulin resistance in the Japanese population, Heise, T. see Heinemann, L. 119 Heller, S.R. see Harris, N.D. Ivanova, 1. see Betts, P.R Henkel, E. see Hanefeld, M. Henriksen, J.E., Bruun Andersen, C., Hother-Nielsen, O., Vaag, A., Aage Mortensen, S. & Beck-Nielsen, H. Impact of Jacob, J. see Taylor, D.J. ubiquinone (coenzyme Qio) treatment on glycaemic control, Jacobsen, P. see Nielsen, F.S. James, T. see Abraha, A. insulin requirement and well-being in patients with Type 1 Jenkinson, C.P. see Flechtner-Mors, M. diabetes mellitus, 312 Jennings, M.K. see Garg, S.K. Hermans, J. see Groeneveld, Y. Johannesen, J. see Lorenzen, T. Hill, R.D. see Laing, S.P. Johannesen, J. see Olsen, B.S. Hinze, S. see Holstein, A. Johnston, G.D. see MCallister, A.S. Hirschberger, S. see Heinemann, L. Jones, A.F. see Bayly, G.R. Ho, L.T. see Hw'u, C.M. Jones, S.C., Saunders, H.J. &c Pollock, C.A. High glucose increases Hod, M., Asatiani, N., Elphick, A., Kurashvili, R., Natsvlishvili, growth and collagen synthesis in cultured human tubuloin¬ M., Chanturia, T., Bar, J. & Peled, Y. Twinning project: Israel terstitial cells, 932 and Georgia - the birth of a Diabetes-in-Pregnancy Centre in Jones, T.H. see Bryant, V.M. Georgia, 645 Jude, E.B. see Tentolouris, N. Hoffman, M. see Levitt, N.S. Jude, E.B., Spittle, M., Connor, H. & Boulton, A.J.M. The Hollis, S. see Van Schie, C.H.M. Diabetic Foot 1998, 170 Holm, G. see Bjorntorp, P. Juliet, K., Mackness, M.L, Dean, J.D. &: Durrington, P.N. Holstein, A., Nahrwold, D., Hinze, S. Sc Egberts, E.-H. Contra¬ Susceptibility of low- and high-density lipoproteins from indications to metformin therapy are largely disregarded, 692 diabetic subjects to itt vitro oxidative modification, 415 Hopmeier, P. see Festa, A. Hopton, M. see Pinkney, J.H. Hother-Nielsen, O. see Henriksen, J.E. Kang, S.-K. see Song, K.-H Hotta, N. see Suzuki, K. Kanters, S.D.J.M., Algra, A., De Bruin, T.W. A., Erkelens, D. W. & Hougaard, P. see Olsen, B.S. Banga, J.-D. Intensive lipid lowering strategy in patients with Howard, E.R. see Ejskjaer, N.T. diabetes mellitus, 500 Howard, N.J. see Duffin, A.C. Karamanos, B. see Collado-Mesa, F. Hsiao, L.C. see Hwu, C.M. Karvonen, M. see Padaiga, Z. Hsueh, E.-J. see Yeh, S.-P. Katsuki, A. see Ito, K. Hughes, P. see Zhao, H.X. Kaufman, J.S. see Wilks, R. Hunter, S.J., Wiggam, M.L, Ennis, C.N., Whitehead, H.M., Kawabata, Y. see Fujisawa, T. Sheridan, B., Atkinson, A.B. & Bell, P.M. Comparison of Kawamura, T. see Suzuki, K. effects of captopril used either alone or in combination with Keen, H. see Laing, S.P. © 1999 British Diabetic Association. Diabetic Medicine, 16, 1051-1064 1056 Indexes Keen, H. see Pierce, M. Lakatos, P. see Winkler, G. Keevil, B.G. see Kilpatrick, E.S. Lambert, E.V. see Levitt, N.S. Keith, P. see Garg, S.K. Lamey, P.-J. see Willis, A.M. Kempler, P. see Collado-Mesa, F. Landstedt-Hallin, L., Arner, P., Lins, P.-E., Bolinder, J., Olsen, H., Kenealy, T. see Simmons, D. Groop, L. Sc The Scandinavian Insulin-Sulphonylurea Study Kennon, B., Petrie, J.R., Small, M. & Connell, J.M.C. Group Research Team. The role of sulphonylurea in combi¬ Angiotensin-converting enzyme gene and diabetes, 448 nation therapy assessed in a trial of sulphonylurea withdrawal, Kerenyi, Z., Stella, P., Nadasdi, A., Tabak, A.G. & Tamas, G. 827 Association between cardiovascular autonomic neuropathy Lanne, T. see Ryden Ahlgren, A. and multi-metabolic syndrome in a special cohort of women Lassmann-Vague, V. see Zevaco-Mattei, C. with prior gestational diabetes mellitus, 794 Lawrenson, R., Leydon, G.M., Williams, T.J., Newson, R.B. Sc Kilpatrick, E.S., Keevil, B.G., Richmond, K.L., Newland, P. Sc Feher, M.D. Patterns of contraception in UK women with Addison, G.M. Plasma 1,5-anhydroglucitol concentrations Type 1 diabetes mellitus: a GP database study, 395 are influenced by variations in the renal threshold for glucose, Lee, B.C., Appleton, M., Shore, A.C., Tooke, J.E. Sc Hattersley, 496 A.T. Impaired maximum microvascular hyperaemia in King, J. see Duffin, A.C. patients with MODY 3 (hepatocyte nuclear factor-la gene Kirk, G. see Elhadd, T. mutations), 731 Knip, M. see Nejentsev, S. Lee, K.-W. see Song, K.-H Knowles, E.A. see Tentolouris, N. Lee, S.H. see Hwu, C.M. Ko, G.T.C., Chan, W.-B., Chan, J.C.N., Tsang, L. W.W. & Lee, Z.S.K. see Ng, M.C.Y. Cockram, C.S. Gastrointestinal symptoms in Chinese patients Lehmann, T. see Morel, Y. with Type 2 diabetes mellitus, 670 Lernmark, B., Persson, B., Fisher, L. Sc Rydelius, P.-A. Symptoms Kobayashi, K. see Nagai, Y. of depression are important to psychological adaptation and Koehler, C. see Hanefeld, M. metabolic control in children with diabetes mellitus , 14 Kohtamaki, K. see Padaiga, Z. Levitt, N.S., Steyn, K., Lambert, E.V., Reagon, G., Lombard, C.J., Koivukangas, V., Annala, A.-P., Salmela, P.I. Sc Oikarinen, A. Fourie, J.M., Rossouw, K. Sc Hoffman, M. Modifiable risk Delayed restoration of epidermal barrier function after suction factors for Type 2 diabetes mellitus in a peri-urban community blister injury in patients with diabetes mellitus, 563 in South Africa, 946 Kong, N. Sc Ryder, R.E.J. What is the role of between meal snacks Levy, J.C. see Farmer, A. with intensive basal bolus regimens using preprandial lispro?, Leydon, G.M. see Lawrenson, R. 325 Li, C.L., Pan, C.Y., Lu, J.H., Zhu, Y., Wang, J.H., Deng, X.X, Konopelska-Bahu, T. see Abraha, A. Xia, F.C., Wang, H.Z. Sc Wang, H.Y. Effect of metformin on Kopelman, P.G. see Diemel, L.T. patients with impaired glucose tolerance, 477 Koppiker, N. see Ammari, F. Li,J.K.Y. see Ng, M.C.Y. Kotsini, V. see Sotiropoulos, A. Librenti, M.C. see Riccardi, G. Kovacs, M. see Winkler, G. Lin, S.H. see Hwu, C.M. Krempf, M. see Colombel, A. Lindner, T.H. see Ng, M.C.Y. Kristiansen, O.P. see Lorenzen, T. Lindstrom, T., Nystrbm, F.H., Olsson, A.G., Ottosson, A.-M. Sc Krolewski, A.S. see Malecki, M.T. Arnqvist, H.J. The lipoprotein profile differs during insulin Krugluger, W. see Festa, A. Kuchly-Anton, B. see Colombel, A. treatment alone and combination therapy with insulin and Kurashvili, R. see Hod, M. sulphonylureas in patients with Type 2 diabetes mellitus, 820 Kwok, C.F. see Hwu, C.M. Lins, P.-E. see Landstedt-Hallin, L. Kyne-Grzebalski, D. see Carron Brown, S. Liolitsa, D. see Stewart, R.J. Kyne-Grzebalski, D., Wood, L., Marshall, S.M. Sc Taylor, R. Lip, G.Y.H. see Elbadd, T. Episodic hyperglycaemia in pregnant women with well- Liptakova, A. see Muchova, J. controlled Type 1 diabetes mellitus: a major potential factor Lo, Y.M.D. see Ng, M.C.Y. underlying macrosomia, 702 Loane, J.F. see O’connor, T.M. Lobisch, M. see Ruhnau, K.-J Laing, P.W'. see Smith, A.L. Lockett, C. see Rajbhandari, S. Laing, S.P., Swerdlow, A.J., Slater, S.D., Botha, J.L., Burden, Loftager, M. see Heinemann, L. A.C., Waugh, N.R., Smith, A.W.M., Hill, R.D., Bingley, P.J., Logatchov, M. see Betts, P.R Patterson, C.C., Qiao, Z. Sc Keen, H. The British Diabetic Lombard, C.J. see Levitt, N.S. Association Cohort Study, I: all-cause mortality in patients London, N.J.M. see White, S.A. with insulin-treated diabetes mellitus, 459 Lorenzen, T., Pociot, F., Johannesen, J., Kristiansen, O.P., Nerup, Laing, S.P., Swerdlow, A.J., Slater, S.D., Botba, J.L., Burden, J., The Danish IDDM Epidemiology Sc Genetics Group. A A.C., Waugh, N.R., Smith, A.W.M., Hill, R.D., Bingley, P.J., population-based survey of frequencies of self-reported Patterson, C.C., Qiao, Z. Sc Keen, H. The British Diabetic spontaneous and induced abortions in Danish women with Association Cohort Study, II; cause-specific mortality in Type 1 diabetes mellitus, 472 patients with insulin-treated diabetes mellitus, 466 Lovgren, T. see Nejentsev, S. , ©1999 British Diabetic Association. Diabetic Medicine, 16 1051-1064 Indexes 1057 Lu, J.H. see Li, C.L. McLaren, M. see Elhadd, T. Luzi, L. see Zerbini, G. McMaster, C. see Hargrave, D.R. Macdonald, LA. see Trojan, N. McNally, P.G. see Davies, M. MacFarlane, LA. see Benbow, S.J. McNally, P.G. see Goyder, E.C. Mackenzie, T. see Garg, S.K. Meeking, D.R., Cummings, M.H., Thorne, S., Donald, A., Mackness, M.I. see Julier, K. Clarkson, P., Crook, J.R., Watts, G.F. &c Shaw, K.M. Mackness, M.I. see Pinkney, J.H. Endothelial dysfunction in Type 1 diabetic subjects with and Macleod, K.M. Diabetes and driving: towards equitable, without microalbuminuria, 841 evidence-based decision-making, 282 Mehnert, M. see Ruhnau, K.-J Mahabir, D. see Gulliford, M.C. Meissner, H.P. see Ruhnau, K.-J Maison, P. see Byrne, C.D. Mejia, A see Gulliford, M.C. Malacara, j.M. see Garay-Sevilla, M.E. Merante, D. see Gregorio, F. Malecki, M.T., Yang, Y., Antonellis, A., Curtis, S., Warram, J.H. Mercier, P. see Zevaco-Mattei, C. & Krolewski, A.S. Identification of new mutations in the Meyboom-De Jong, B. see Goddijn, P.P.M. hepatocyte nuclear 4a gene among families with early onset Michel, G. see Collado-Mesa, F. Type 2 diabetes mellitus, Millward, B.A. see Zhao, H.X. 193 Miossec, P., Zkhiri, F., Paries, J., David-Dufilho, M., Devynck, Manfrini, S. see Gregorio, F. M.A. & Valensi, E. Effect of pravastatin on erythrocyte Mangili, R. see Zerbini, G. rheological and biochemical properties in poorly controlled Manicardi, E. see Gaddi, O. Type 2 diabetic patients, 424 Mannucci, E. see Galeone, F. Mires, G.J., Williams, F.L.R. & Harper, V. Screening practices for Mannucci, E., Bardini, G., Ognibene, A. & Rotella, C.M. gestational diabetes mellitus in UK obstetric units, 138 Comparison of ADA and WHO screening methods for Mirsky, N. see Ravina, A. diabetes mellitus in obese patients, 579 Moller, N. see 0rskov, L. Mantey, L, Foster, A.V.M., Spencer, S. 8c Edmonds, M.E. Why do Molyneaux, L. see Mcfarlane, R. foot ulcers recur in diabetic patients?, 245 Moneta, 1. see Gaddi, O. Marescotti, M.C. see Trojan, N. Monteduro, M. see Riccardi, G. Marinelli, K. see Olsen, B.S. Morel, Y., Golay, A., Perneger, T., Lehmann, T., Vadas, L., Pasik, Marra, G. see Riccardi, G. C. & Reaven, G.M. Metformin treatment leads to an increase Marsden, J. see Winkler, A.S. in basal, but not insulin-stimulated, glucose disposal in obese Marshall, S.M. Blood pressure control, microalbuminuria and patients with impaired glucose tolerance, 650 cardiovascular risk in Type 2 diabetes mellitus, 358 Moro, E., Alessandrini, P., Zambon, C., Pianetti, S., Pais, M., Marshall, S.M. see Alberti, K.G.M.M. Cazzolato, G. & Bittolo Bon, G. Is glycation of low density Marshall, S.M. see Kyne-Grzebalski, D. lipoproteins in Type 2 diabetic patients an LDL pre-oxidative Martensz, N. see Byrne, C.D. condition?, 663 Mason, J., O’Keeffe, C., Hutchinson, A., Mcintosh, A., Young, R. Mortensen, H.B. see Olsen, B.S. & Booth, A. A systemic review of foot ulcer in patients with Muchova, J., Liptakova, A., Orszaghova, Z., Garaiova, L, Tison, Type 2 diabetes mellitus. II: treatment, 889 P., Carsky, J. &C Durackova, Z. Antioxidant systems in Mason, J., O’Keeffe, C., Mcintosh, A., Hutchinson, A., Booth, A. polymorphonuclear leucocytes of Type 2 diabetes mellitus, 74 & Young, R.J. A systemic review of foot ulcer in patients with Muehlbayer, S. see Davies, M. Type 2 diabetes mellitus. 1: prevention, 801 Murat, A. see Colombel, A. Mather, H.M. see Colhoun, H.M. Murata, K. see Ito, K. Mathers, J.C. see Alberti, K.G.M.M. Murphy, H. see Betts, P.R Matthews, D.R. see Abraha, A. Mwangi, B. see Carton Brown, S. Matthews, D.R. see Ahmed, S. McAllister, A.S., Atkinson, A.B., Johnston, G.D. & Mccance, Nadasdi, A. see Kerenyi, Z. D.R. Endothelial function in offspring of Type 1 diabetic Nagai, Y., Takamura, T., Nohara, E., Yamashita, H. & patients with and without diabetic nephropathy, 298 Kobayashi, K. Serum soluble adhesion molecule Mccance, D.R. see Mcallister, A.S. concentrations are not regulated by acute hyperinsulinaemia Mccredie, R.J. see Mcfarlane, R. in healthy men, 618 McFarlane, R., Mccredie, R.J., Bonney, M.-A., Molyneaux, L., Nagy, Z. see Winkler, G. Zilkens, R., Celermajer, D.S. & Yue, D.K. Angiotensin¬ Nahrwold, D. see Holstein, A. converting enzyme inhibition and arterial endothelial function Nairn, C., Galbraith, D.N., Taylor, K.W. & Clements, G.B. in adults with Type 1 diabetes mellitus , 62 Enterovirus variants in the serum of children at the onset of McFarlane-Anderson, N. see Wilks, R. Type 1 diabetes mellitus, 509 Mclnnes, A. see Duffin, A.C. Nakagawa, Y see Fujisawa, T. McIntosh, A. see Mason, J. Nakatani, K. see Ito, K. McIntosh, A. see Mason, J. Natsvlishvili, M. see Hod, M. McKinney, P.A. see Fear, N.T. Nehrdich, D. see Ruhnau, K.-J , ©1999 British Diabetic Association. Diabetic Medicine, 16 1051-1064 1058 Indexes Nejentsev, S., Sjoroos, M., Soukka, T., Knip, M., Simell, O., on hepatic glucagon responses and intermediary metabolism Lovgren, T. & Ilonen, J. Population-based genetic screening in Type 1 diabetic subjects, 867 for the estimation of Type 1 diabetes mellitus risk in Finland: Orszaghova, Z. see Muchova, J. selective genotyping of markers in HLA-DQBl, HLA-DQAl Ottosson, A.-M. see Lindstrom, T. and HLA-DRBl loci, 985 Nerup, J. see Lorenzen, T. Pacini, G. see Trojan, N. Newland, P. see Kilpatrick, E.S. Padaiga, Z., Tuomilehto, J., Karvonen, M., Dahlquist, G., Newson, R.B. see Lawrenson, R. Podar, T., Adojaan, B., Urbonaite, B., Zalinkevicius, R., Newton, R. see Elhadd, T. Brigis, G., Virtala, E., Kohtamaki, K., Cepaitis, Z. &c Ng, M.C.Y., Cockburn, B.N., Lindner, T.H., Yeung, V.T.F., Tuomilehto-Wolf, E. Seasonal variation in incidence of Chow, C.-C, So, W.-Y., Li, J.K.Y., Lo, Y.M.D., Lee, Z.S.K., Type 1 diabetes mellitus during 1983 to 1992 in the Cockram, C.S., Critchley, J.A.J.H., Bell, G.I. & Chan, J.C.N. countries around the Baltic Sea, 736 Molecular genetics of diabetes mellitus in Chinese subjects: Page, S.R. see Gazis, A. identification of mutations in glucokinase and hepatocyte Pais, M. see Moro, E. nuclear factor-la genes in patients with early-onset Type 2 Pan, C.Y. see Li, C.L. diabetes mellitus/MODY, 956 Pantaleoni, M. see Gaddi, O. Nicholson, M.L. see White, S.A. Pappas, S.l. see Sotiropoulos, A. Nielsen, E.S. see Christensen, P.K. Paries, J. see Miossec, P. Nielsen, F.S., Hansen, H.P., Jacobsen, P., Rossing, P., Smidt, Parillo, M. see Riccardi, G. U.M., Christensen, N.J., Pevet, P., Vivien-Roels, B, & Parving, Parslow, R.C. see Fear, N.T. H.-H. Increased sympathetic activity during sleep and Parving, H.-H. see Christensen, P.K. nocturnal hypertension in Type 2 diabetic patients with Parving, H.-H. see Nielsen, F.S. diabetic nephropathy, 555 Pasik, C. see Morel, Y. Nishino, T. see Fujisawa, T. Patel, S., Unwin, N., Bhopal, R., White, M., Harland, J., Ayis, Nohara, E. see Nagai, Y. S.A.M., Watson, W. 8c Alberti, K.G.M.M. A comparison of Nojima, K. see Fujisawa, T. proxy measures of abdominal obesity in Chinese, European Nonaka, K. see Ichikawa, F. and South Asian adults, 853 Norman, G. see Gerstein, H.C. Paton, R.C. & Sathiavageeswaran, M. Severe diabetic keto¬ Noso, S. see Fujisawa, T. acidosis, 884 Nyholm, B. see 0rskov, L. Paterson, K.R. Diabetes epidemiology: present and future, 446 Nystrom, F.H. see Lindstrom, T. Patterson, C.C. see Fear, N.T. Patterson, C.C. see Laing, S.P. O’Connor, T.M., Cronin, C.C., Loane, J.F., O’Meara, N.M., Pavan, P. see Trojan, N. Firth, R.G., Shanahan, F. & O’Halloran, D.J. Type 1 diabetes Peakman, M. see Ejskjaer, N.T. mellitus, coeliac disease and lymphoma: a report of four cases, Peled, Y. see Hod, M. 614 Peppas, T.A. see Sotiropoulos, A. O’Halloran, D.J. see O’Connor, T.M. Perneger, T. see Morel, Y. O’Hare, M.M.T. see Hargrave, D.R. Perry, S.V. see Garg, S.K. O’Keeffe, C. see Mason, J. Persson, B. see Lernmark, B. O’Meara, N.M. see O’Connor, T.M. Peto, R. see Baigent, C. O’Rahilly, S.P. The metabolic syndrome: all in the mind?, 355 Petri, FL see Groeneveld, Y. Oghiara, T. see Fujisawa, T. Petrie, J.R. see Kennon, B. Ognibene, A. see Mannucci, E. Pevet, P. see Nielsen, F.S. Ohguro, N. see Fujisawa, T. Pianetti, S. see Moro, E. Oikarinen, A. see Koivukangas, V. Picano, E. see Gaddi, O. Okada, K. see Uchimoto, S. Pierce, M., Hayworth, J., Warburton, F., Keen, H. & Bradley, C. Okamoto, N. see Fujisawa, T. Diabetes mellitus in the family: perceptions of offspring’s risk, Olsen, B.S., Johannesen, J., Sjelie, A.K., Borch-Johnsen, K., 431 Hougaard, P., Thorsteinsson, B., Pramming, S., Marinelli, K., Pinkney, J.H., Downs, L, Hopton, M., Mackness, M.L & Bolton, Mortensen, H.B. & The Danish Study Group Of Diabetes In C.H. Endothelial dysfunction in Type 1 diabetes mellitus: Childhood. Metabolic control and prevalence of microvascu- relationship with LDL oxidation and effects of vitamin E, 993 lar complications in young Danish patients with Type 1 Piolot, R. see Rausch, U. diabetes mellitus, 79 Plehwe, W.E. see Wood, D.M. Olsen, H. see Landstedt-Hallin, L. Pociot, F. see Lorenzen, T. Olsson, A.G. see Lindstrom, T. Podar, T. see Padaiga, Z. Ono, M. see Fujisawa, T. Pollock, C.A. see Jones, S.C. Oreland, L. see Garpenstrand, H. Pontiroli, A.E. see Riccardi, G. Orskov, L., Nyholm, B., Yde Hove, K.,, C., Gravholt, H., Moller, Potter, M. see Duffin, A.C. N. & Schmitz, O. Effects of the amylin analogue pramlintide Poulsen, P. see Christiansen, C. ©1999 British Diabetic Association. Diabetic Medicine, 16, 1051-1064 i»:ji Indexes 1059 Poulter, N.R. see Colhoun, H.M. with the antioxidant thioctic acid (a-lipoic acid) in sympto¬ Pozza, G. see Riccardi, G. matic diabetic polyneuropathy, 1040 Pramming, S. see Olsen, B.S. Rydelius, P.-A. see Lernmark, B. Prasad, S. Survey diabetic retinopathy screening services in Ryden Ahlgren, A., Sundkvist, G., Wollmer, P., Sonesson, B. &; England and Wales, 269 Lanne, T. Increased aortic stiffness in women with Type 1 Purewal, T. see Ejskjaer, N.T. diabetes mellitus is associated with diabetes duration and autonomic nerve function, 291 Qiao, Z. see Laing, S.P. Ryder, R.E.j. see Kong, N. Rajbhandari, S., Harris, N.D., Sutton, M., Lockett, C., Eaton, S., Sakakibara, F. see Suzuki, K. Sakamoto, N. see Suzuki, K. Gadour, M., Tesfaye, S. & Ward, J.D. Digital imaging; an Salamon, F. see Winkler, G. accurate and easy method of measuring foot ulcers, 339 Salmela, P.I. see Koivukangas, V. Ramachandran, A. see Snehalatha, C. Sanderson, E. see Zhao, H.X. Rausch, U., Ziegler, D., Piolot, R., Schwippert, B., Benthake, H., Sano, T. see Suzuki, K. Schultheiss, H.-P. & Tschoepe, D. Platelet activation in Santeusanio, F. see Riccardi, G. diabetic cardiovascular autonomic neuropathy, 848 Sasaki, H. see Suzuki, K. Ravina, A., Slezak, L., Mirsky, N., Bryden, N.A. & Anderson, Sathiavageeswaran, M. see Paton, R.C. R.A. Reversal of corticosteroid-induced diabetes mellitus with Satyavani, K. see Snehalatha, C. supplemental chromium, 164 Saunders, H.j. see Jones, S.C. Reagon, G. see Levitt, N.S. Schaper, F. see Hanefeld, M. Reaven, G.M. see Morel, Y. Schaumkel, J. see Simmons, D. Reddy, S.S.K. see Gerstein, H.C. Schernthaner, G. see Festa, A. Reilly, A. see Clarke, C.F. Schmitz, O. see 0rskov, L. Reljanovic, M. see Ruhnau, K.-J Schultheiss, H.-P. see Rausch, U. Mukherjee, A. Living with Diabetes for Those Treated with Diet Schultz, C. see Abraha, A. and Tablets, 268 Schiitte, K. see Ruhnau, K.-J Winkler, A. Clinical Management of Diabetic Neuropathy, 267 Schwippert, B. see Rausch, U. Reviron, D. see Zevaco-Mattei, C. Scobie, I.N. Spontaneous muscle infarction in diabetes: a pain in Riccardi, G., Parillo, M., Turco, S., Rivellese, A.A., Ventura, the leg, 91 M.R., Contadini, S., Marra, G., Monteduro, M., Scott, D.J. see Simmons, D. Santeusanio, F., Brunetti, P., Librenti, M.C., Pontiroli, Shanahan, F. see O’Connor, T.M. A.E., Vendani, P., Pozza, G., Bergamini, L. & Bianchi, C. Shannon, S. see Gerstein, H.C. Efficacy and safety of acarbose in treatment of Type 1 Shaw, J.E. see Van Schie, C.H.M. diabetes mellitus: a placebo-controlled, double-blind, Shaw, K.M. see Meeking, D.R. multicentre study, 228 Shen, G.-Q. see Fujisawa, T. Richmond, K.L. see Kilpatrick, E.S. Sheridan, B. see Hunter, S.J. Rios, M. see Costa, A. Sherriff, C. see Davies, M.J. Rivellese, A.A. see Riccardi, G. Shih, K.C. see Hwu, C.M. Roberts, N.B. see Wiener, K. Shintani, M. see Fujisawa, T. Robinson, A. see Alberti, K.G.M.M. Shnawa, N. see Festa, A. Rodriguez-Villar, C., Conget, 1., Casamitjana, R., Ercilla, G. 8c Shore, A.C. see Lee, B.C. Gomis, R. Effects of insulin administration in a group of high- Siegert, G. see Hanefeld, M. risk, non-diabetic, first-degree relatives of Type 1 diabetic Silink, M. see Duffin, A.C. patients: an open pilot trial, 160 Simell, O. see Nejentsev, S. Roglic, G. see Collado-Mesa, F. Simmons, D. Screening for Type 2 diabetes mellitus in the UK Rosenqvist, U. see Garpenstrand, H. Indo-Asian population, 795 Rosenthal, J.M. Living with Diabetes for those Treated with Simmons, D., Schaumkel, J., Cecil, A., Scott, D.J. & Kenealy, T. Insulin, 707 High impact of nephropathy on five-year mortality rates Rosmond, R. see Bjorntorp, P. among patients with Type 2 diabetic mellitus from a multi¬ Rossing, P. see Christensen, P.K. ethnic population in New Zealand, 926 Rossing, P. see Nielsen, F.S. Simonin, G. see Zevaco-Mattei, C. Rossouw, K. see Levitt, N.S. Sinha, K. see Heinemann, L. Rotella, C.M. see Mannucci, E. Sivasankari, S. see Snehalatha, C. Rotimi, C. see Wilks, R. Sjolie, A.K. see Olsen, B.S. Ruge, D. see Willms, B. Sjdroos, M. see Nejentsev, S. Ruhnau, K.-J, Meissner, H.P., Finn, j.-R., Reljanovic, M., Skliros, E. see Sotiropoulos, A. Lobisch, M., Schiitte, K., Nehrdich, D., Tritschler, H.J., Slater, S.D. see Laing, S.P. .Mehnert, M. & Ziegler, D. Effects of 3-week oral treatment Slater, S.D. see Laing, S.P. , ©1999 British Diabetic Association. Diabetic Medicine, 16 1051-1064 •:jii 1060 Indexes Slezak, L. see Ravina, A. Taylor, D.J., Fisher, J., Jacob, J. 8c Tooke, J.E. The use of digital Small, M. see Kennon, B. cameras in a mobile retinal screening environment, 680 Smidt, U.M. see Nielsen, F.S. Taylor, K.W. see Nairn, C. Smirnof, I. see Tentolouris, N. Taylor, R. see Carron Brown, S. Smith, A. The Diabetes Annual 11, 797 Taylor, R. see Kyne-Grzebalski, D. Smith, A.L. & Laing, P.W. Spontaneous tibial compartment Temelkova-Kurktschiev, T. see Hanefeld, M. syndrome in Type 1 diabetes mellitus, 168 Tentolouris, N., Jude, E.B., Smirnof, L, Knowles, E.A. 8c Boulton, Smith, A.W.M. see Laing, S.P. A.J.M. Methicillin-resistant Straphylococcus aureus-, an in¬ Smith, A.W.M. see Laing, S.P. creasing problem in a diabetic foot clinic, 767 Snehalatha, C., Satyavani, K., Sivasankari, S., Vijay, V. & Tesfaye, S. see Rajbhandari, S. Ramachandran, A. Insulin secretion and action in different Testa, R. see Gregorio, F. stages of glucose tolerance in Asian Indians, 408 The Danish Study Group Of Diabetes In Childhood see Olsen, B.S. So, W.-Y. see Ng, M.C.Y. The EURODIAB IDDM Complications Study Group see Son, H.-Y. see Song, K.-H Collado-Mesa, F. Sonesson, B. see Ryden Ahlgren, A. The Microalbuminuria Collaborative Study Group. Predictors of Song, K.-H, Ahn, Y.-B., Yoon, K.-H., Cha, B.-Y., Lee, K.-W., Son, development of microalbuminuria in patients with Type 1 H.-Y. & Kang, S.-K. The effect of long-term glycaemic control diabetic mellitus: a seven-year prospective study, 918 on serum lipoprotein(a) levels in patients with Type 2 diabetes The Ramadan Study Group see Akram, J. mellitus, 1036 The Scandinavian Insulin-Sulphonylurea Study Group Research Sbnksen, P.H. see Coppini, D.V. Team, see Landstedt-Hallin, L. Soper, C. see Zhao, H.X. The Troglitazone Study Group see Buysschaert, M. Sotiropoulos, A., Peppas, T.A., Skliros, E., Apostolou, O., Thomas, P.K. see Ejskjaer, N.T. Kotsini, V. & Pappas, S.I. Low prevalence of hepaptitis C virus Thomas, S.M. Microalbuminuria. Biochemistry, Epidemiology infection in Greek diabetic patients, 250 and Clinical Practice, 707 Soukka, T. see Nejentsev, S. Thorne, S. see Meeking, D.R. Southampton, J. see Betts, P.R Thorsteinsson, B. see Olsen, B.S. Speer, G. see Winkler, G. Tiengo, A. see Trojan, N. Spencer, S. see Mantey, 1. Tison, P. see Muchova, J. Spiers, N. see Goyder, E.C. Todd, J.A. see Ahmed, S. Spittle, M. see Jude, E.B. Tomlinson, D.R. see Diemel, L.T. Springer, M.P. see Groeneveld, Y. Tomlinson, S. see Hawthorne, K. Stahl, M. & Berger, W. Higher incidence of severe hypoglycaemia Tooke, J.E. 8c Goh, K.L. Vascular function in Type 2 diabetes leading to hospital admission in Type 2 diabetic patients treated mellitus and pre-diabetes: the case for intrinsic endothelio- with long-acting versus short-acting sulphonylureas, 586 pathy, 710 Starkie, M. see Buysschaert, M. Tooke, J.E. see Brash, P.D. Stella, P. see Kerenyi, Z. Tooke, J.E. see Lee, B.C. Stenhouse, E. see Zhao, H.X. Tooke, J.E. see Taylor, D.J. Stevens, L.K. see Collado-Mesa, F. Tortorella, G. see Gaddi, O. Stewart, R.J. 8c Liolitsa, D. Type 2 diabetes mellitus, cognitive Tritschler, H.J. see Ruhnau, K.-J impairment and dementia, 93 Trojan, N., Pavan, P., lori, E., Vettore, M., Marescotti, M.C., Steyn, K. see Levitt, N.S. Macdonald, LA., Tiengo, A., Pacini, G. 8c Avogaro, A. Effect Stratton, I.M. see Abraha, A. of different times of administration of a single ethanol dose on Suematsu, C. see Uchimoto, S. insulin action, insulin secretion and redox state, 400 Sumida, Y. see Ito, K. Tsang, L.W.W. see Ko, G.T.C. Sundkvist, G. see Gottsater, A. Tschoepe, D. see Rausch, U. Sundkvist, G. see Ryden Ahlgren, A. Tsuchihashi, K. see Ito, K. Sutton, M. see Rajbhandari, S. Tsumara, K. see Uchimoto, S. Suzuki, K., Kawamura, T., Sakakibara, F., Sasaki, H., Sano, T., Tula, J. see Betts, P.R Sakamoto, N. & Hotta, N. Effect of aldose reductase Tuomilehto, J. see Padaiga, Z. inhibitors on glucose-induced changes in sorbitol and myo¬ Tuomilehto-Wolf, E. see Padaiga, Z. inositol metabolism in human neutrophils, 67 Turco, S. see Riccardi, G. Swerdlow, A.J. see Laing, S.P. Turner, R.C. see Farmer, A. Twyman, S. see Betts, P.R Tabak, A.G. see Kerenyi, Z. Takamura, T. see Nagai, Y. Tamas, G. see Kerenyi, Z. Uchimoto, S., Tsumara, K., Hayashi, T., Suematsu, C., Endo, G., Tambov, J. see Betts, P.R Fujii, S. 8c Okada, K. Impact of cigarette smoking on the Tattersall, R.B. A paper which changed clinical practice (slowly). incidence of Type 2 diabetes mellitus in middle-aged Japanese Jacob Holler on potassium deficiency in diabetic acidosis men: the Osaka Health Survey, 951 (1946), 978 Ueda, H. see Fujisawa, T. ©1999 British Diabetic Association. Diabetic Medicine, 16, 1051-1064

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.